Trial Details

COMPLETED
Basic Information
Clinical ID c1729
Identifier NCT04598295
Trial Title SH-DS01 on Fecal Metagenomic Stability
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Irritable Bowel Syndrome
Interventions DRUG: DS-01
Participant Information
Sponsor Beth Israel Deaconess Medical Center
City Boston
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2020-10-20
Primary Completion Date 2022-10-17
Completion Date 2022-10-26